Adirondack Research & Management’s Artivion AORT Stock Holding History

Adirondack Research & Management’s Portfolio AORT Stock Details AORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-136,135	Closed	-$2.39M	–	109
2016 Q3	$2.39M	Sell	136,135 -140,988	-51%	-$2.13M	0.86%	51
2016 Q2	$3.27M	Hold	277,123	–	–	1.23%	40
2016 Q1	$2.98M	Buy	277,123 +4,200	+2%	+$42.7K	1.08%	46
2015 Q4	$2.94M	Hold	272,923	–	–	1.06%	42
2015 Q3	$2.66M	Hold	272,923	–	–	1.02%	48
2015 Q2	$3.08M	Hold	272,923	–	–	1.13%	48
2015 Q1	$2.83M	Sell	272,923 -21,504	-7%	-$237K	1.1%	42
2014 Q4	$3.34M	Hold	294,427	–	–	1.25%	38
2014 Q3	$2.91M	Hold	294,427	–	–	1.08%	47
2014 Q2	$2.63M	Hold	294,427	–	–	0.89%	58
2014 Q1	$2.93M	Buy	294,427 +6,470	+2%	+$66.3K	1.12%	44
2013 Q4	$3.19M	Buy	287,957 +6,100	+2%	+$57.4K	1.55%	26
2013 Q3	$1.97M	Buy	281,857 +15,895	+6%	+$108K	1.14%	46
2013 Q2	$1.67M	Buy	+265,962	New	+$1.62M	1.24%	37

Other funds holding AORT

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Adirondack Research & Management's AORT Position: Q4 2016 in Review

Adirondack Research & Management sold out of Artivion (AORT) in Q4 2016, closing a stake of 136,135 shares — an estimated $2.39M sold.

Adirondack Research & Management first reported a position in AORT in Q2 2013 and held it in 14 quarters. The position peaked at $3.34M in Q4 2014. 138 funds tracked by Wall St. Rank hold AORT as of Q4 2016.

Adirondack Research & Management reported no remaining Artivion position as of Q4 2016 after selling out during the quarter.
Adirondack Research & Management sold 136,135 Artivion shares in Q4 2016, an estimated $2.39M.
Adirondack Research & Management first reported a position in Artivion in Q2 2013 and held it in 14 quarters.
Adirondack Research & Management's Artivion position peaked at $3.34M in Q4 2014.
138 funds tracked by Wall St. Rank held Artivion as of Q4 2016.

Based on Adirondack Research & Management's 13F filing for Q4 2016, filed 8 Feb 2017.